Hydrocortisone BE studies for UK [Design Issues]

posted by HallaGulla – 2022-05-16 19:37 (1068 d 19:03 ago) – Posting: # 22992
Views: 2,063

Dear All

It would be great if someone can put some light on dose linearity for Hydrocortisone acetate. The information available in the literature is very confusing with few suggesting it's linear between the dose up to 40mg and then few say nonlinear due to absorption and protein binding and show less than dose-proportional increase in AUC.


In case we have to plan this study for the EU/UK do we need to do a study on higher and lower strength both?

Cheers
HG

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,699 registered users;
26 visitors (0 registered, 26 guests [including 5 identified bots]).
Forum time: 14:40 CEST (Europe/Vienna)

Do not put your faith in what statistics say until you have carefully
considered what they do not say.    William W. Watt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5